Sentinel hospital surveillance for rotavirus in Latin American and caribbean countries

Journal of Infectious Diseases

Volumn 200, Issue SUPPL. 1, 2009, Pages

  De Oliveira, Lucia Helena ^a   Carolina Danovaro Holliday, M ^a   Andrus, Jon Kim ^a   De Fillipis, Ana Maria Bispo ^a   Gentsch, Jon ^b   Matus, Cuauhtemoc Ruiz ^a   Widdowson, Marc Alain ^b  

^a PAN AMERICAN HEALTH ORGANIZATION   (United States)

^b NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ROTAVIRUS VACCINE;

ACUTE DIARRHEA; ARTICLE; CAUSE OF DEATH; CENTRAL AMERICA; CHILD; DISEASE DURATION; DISEASE SURVEILLANCE; EPIDEMIOLOGICAL DATA; FECES ANALYSIS; GENOTYPE; HOSPITALIZED CHILD; HUMAN; LOOSE FECES; MAJOR CLINICAL STUDY; MORTALITY; PRESCHOOL CHILD; PRIORITY JOURNAL; ROTAVIRUS; SEASONAL VARIATION; SOUTH AND CENTRAL AMERICA; VIRUS DETECTION; VIRUS INFECTION; VIRUS STRAIN; WINTER; WORLD HEALTH ORGANIZATION;

CARIBBEAN REGION; CHILD, PRESCHOOL; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; LATIN AMERICA; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; TIME FACTORS; VACCINATION;

EID: 72849114121     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/605060     Document Type: Article

References (23)

1. World Health Organization. Estimated rotavirus deaths for childrenunder 5 years of age: 2004. Available at http://www.who.int/immunization-monitoring/ burden/rotavirus-estimates/en/index.html. Accessed 11 May 2008.
2. Vesikari T, Matson DO, Dennehy P, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006; 354:23-33. (Pubitemid 43048948) (Pubitemid 43048948)
3. Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006; 354:11-22. (Pubitemid 43048947) (Pubitemid 43048947)
4. WHO position paper on rotavirus vaccines. Wkly Epidemiol Rec 2007; 82:285-296
5. de Oliveira LH, Danovaro-Holliday MC, Matus CR, Andrus JK. Rotavirus vaccine introduction in the Americas: progress and lessons learned. Expert Rev Vaccines 2008; 7:345-353
6. Kane EM, Turcios RM, Arvay ML, Garcia S, Bresee JS, Glass RI. The epidemiology of rotavirus diarrhea in Latin America: anticipating rotavirus vaccines. Rev Panam Salud Publica 2004; 16:371-377 (Pubitemid 40070966)
7. Pan American Health Organization. Vigilancia epidemioló gica de diarreas causadas por rotavirus: guía Práctica. Organización Panamericana de la Salud 2007; 623.
8. Gouvea V, Glass RI, Woods P, et al. Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens. J Clin Microbiol 1990; 28:276-282 (Pubitemid 20050935)
9. Das BK, Gentsch JR, Cicirello HG, et al. Characterization of rotavirus strains from newborns in New Delhi, India. J Clin Microbiol 1994; 32:1820-1822
10. Gentsch JR, Glass RI,Woods P, et al. Identification of group A rotavirus gene 4 types by polymerase chain reaction. J Clin Microbiol 1992; 30: 1365-1373
11. Griffin DD, Nakagomi T, Hoshino Y, et al. Characterization of nontypeable rotavirus strains from the United States: identification of a new rotavirus reassortant (P2A[6],G12) and rare P3[9] strains related to bovine rotaviruses. Virology 2002; 294:256-269
12. Boschi-Pinto C, Velebit L, Shibuya K. Estimating child mortality due to diarrhoea in developing countries. Bull WHO 2008; 86:710-717
13. LeBaron CW, Lew J, Glass RI, Weber JM, Ruiz-Palacios GM. Annual rotavirus epidemic patterns in North America: results of a five-year retrospective survey of 88 centers in Canada, Mexico, and the United States. JAMA 1990; 264:983-988 (Pubitemid 20260909) (Pubitemid 20260909)
14. Vesikari T, Karvonen A, Prymula R, et al. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet 2007; 370:1757-1763 (Pubitemid 350137490) (Pubitemid 350137490)
15. Linhares AC, Velazquez FR, Perez-Schael I, et al. Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study. Lancet 2008; 371:1181-1189
16. Bresee J, Fang ZY, Wang B, et al. First report from the Asian Rotavirus Surveillance Network. Emerg Infect Dis 2004; 10:988-995 (Pubitemid 38697688)
17. Kim JS, Kang JO, Cho SC, et al. Epidemiological profile of rotavirus infection in the Republic of Korea: results from prospective surveillance in the Jeongeub District, 1 July 2002 through 30 June 2004. J Infect Dis 2005; 192(Suppl 1):S49-56.
18. Nakagomi T, Nakagomi O, Takahashi Y, Enoki M, Suzuki T, Kilgore PE. Incidence and burden of rotavirus gastroenteritis in Japan, as estimated from a prospective sentinel hospital study. J Infect Dis 2005; 192(Suppl 1):S106-10.
19. Parashar UD, Gibson CJ, Bresee JS, Glass RI. Rotavirus and severe childhood diarrhea. Emerg Infect Dis 2006; 12:304-306
20. Brandt CD. Rotavirus gastroentesteritis and weather. J Clin Microbiol 1982; 16:478-482
21. Ansari SA, Sattar SA, Springthorpe VS, Wells GA, Tostowaryk W. Rotavirus survival on human hands and transfer of infectious virus to animate and nonporous inanimate surfaces. J Clin Microbiol 1988; 26: 1513-1518 (Pubitemid 18184868)
22. Cook SM, Glass RI, LeBaron CW, Ho M-S. Global seasonality of rotavirus infections. Bull WHO 1990; 68:171-177
23. Centers for Disease Control and Prevention. Delayed onset and diminished magnitude of rotavirus activity - United States, November 2007-May 2008. MMWR Morb Mortal Wkly Rep 2008; 57:697-700.